UBS Group’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Sell |
37,499
-13,700
| -27% | -$78.9K | ﹤0.01% | 5432 |
|
|
2025
Q1 | $168K | Buy |
51,199
+23,199
| +83% | +$76.1K | ﹤0.01% | 5410 |
|
|
2024
Q4 | $88.8K | Sell |
28,000
-5,000
| -15% | -$15.9K | ﹤0.01% | 5734 |
|
|
2024
Q3 | $86.8K | Buy |
33,000
+3,410
| +12% | +$8.97K | ﹤0.01% | 5266 |
|
|
2024
Q2 | $76.3K | Buy |
+29,590
| New | +$76.3K | ﹤0.01% | 5221 |
|